Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218556 · ClinicalTrials.gov registry record · NA
Preventing Depression in Methadone Maintenance Patients Receiving Hepatitis C Treatment - 1
A NA study of Hepatitis C and Depressive Disorder, Major, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT00218556 is a NA study of Hepatitis C and Depressive Disorder, Major that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 42 participants, below the 1,890-participant average among 106 other Hepatitis C trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00218556, a NA study of Hepatitis C and Depressive Disorder, Major, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is develop and test a cognitive-behavioral intervention to prevent depression in methadone maintenance patients receiving medical treatment for hepatitis C.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive behavioral treatment for depression
Study Locations (1)
Rhode Island
- Rhode Island Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2004-01 |
| Est. Completion | 2008-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00218556
The ClinicalTrials.gov registry entry for NCT00218556 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,890-participant average among 106 other Hepatitis C trials with a reported enrollment target (98% lower). The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hepatitis C appearing as the primary indexed condition, and to 1 intervention - of which Cognitive behavioral treatment for depression is the first listed.
NCT00218556 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.
Frequently Asked Questions
What is clinical trial NCT00218556 about?
NCT00218556 is a clinical study titled "Preventing Depression in Methadone Maintenance Patients Receiving Hepatitis C Treatment - 1". The purpose of this study is develop and test a cognitive-behavioral intervention to prevent depression in methadone maintenance patients receiving medical treatment for hepatitis C.
What is the current status of trial NCT00218556?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2004-01. Estimated completion is 2008-06.
What conditions does trial NCT00218556 study?
This clinical trial studies the following conditions: Hepatitis C, Depressive Disorder, Major.
What interventions are being tested in trial NCT00218556?
The interventions under investigation include: Cognitive behavioral treatment for depression (BEHAVIORAL).
Who is sponsoring clinical trial NCT00218556?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00218556 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis C
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
RECRUITING · NA
-
HCV Tappt Adherence Study
RECRUITING · NA
-
Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
RECRUITING · NA
-
Buprenorphine Integration Research and Community Health
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.